371 related articles for article (PubMed ID: 15771451)
1. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
2. Coordination chemistry of the antitumor metallocene molybdocene dichloride with biological ligands.
Waern JB; Harding MM
Inorg Chem; 2004 Jan; 43(1):206-13. PubMed ID: 14704069
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity and transmission electron microscopy studies of molybdocene dichloride.
Campbell KS; Foster AJ; Dillon CT; Harding MM
J Inorg Biochem; 2006 Jul; 100(7):1194-8. PubMed ID: 16527357
[TBL] [Abstract][Full Text] [Related]
4. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of the antitumour metallocenes Cp(2)MCl(2) (M = Mo, Ti) with cucurbit[n]urils.
Buck DP; Abeysinghe PM; Cullinane C; Day AI; Collins JG; Harding MM
Dalton Trans; 2008 May; (17):2328-34. PubMed ID: 18414758
[TBL] [Abstract][Full Text] [Related]
6. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-inducing vanadocene compounds against human testicular cancer.
Ghosh P; D'Cruz OJ; Narla RK; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1536-45. PubMed ID: 10778987
[TBL] [Abstract][Full Text] [Related]
8. A (1)H NMR study of the interaction of antitumor metallocenes with glutathione.
Mokdsi G; Harding MM
J Inorg Biochem; 2001 Sep; 86(2-3):611-6. PubMed ID: 11566334
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
10. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Peacock AF; Parsons S; Sadler PJ
J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.
Kostova I; Momekov G; Zaharieva M; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):542-51. PubMed ID: 15922838
[TBL] [Abstract][Full Text] [Related]
12. Intracellular mapping of the distribution of metals derived from the antitumor metallocenes.
Waern JB; Harris HH; Lai B; Cai Z; Harding MM; Dillon CT
J Biol Inorg Chem; 2005 Aug; 10(5):443-52. PubMed ID: 15906108
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium(III) maltolato-nitroimidazole complexes: synthesis and biological activity.
Kennedy DC; Wu A; Patrick BO; James BR
J Inorg Biochem; 2006 Dec; 100(12):1974-82. PubMed ID: 16938347
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.
Thomadaki H; Karaliota A; Litos C; Scorilas A
J Med Chem; 2007 Mar; 50(6):1316-21. PubMed ID: 17328533
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
17. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.
Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ
Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361
[TBL] [Abstract][Full Text] [Related]
18. Palladium(II) complexes of 2-benzoylpyridine-derived thiosemicarbazones: spectral characterization, structural studies and cytotoxic activity.
Rebolledo AP; Vieites M; Gambino D; Piro OE; Castellano EE; Zani CL; Souza-Fagundes EM; Teixeira LR; Batista AA; Beraldo H
J Inorg Biochem; 2005 Mar; 99(3):698-706. PubMed ID: 15708790
[TBL] [Abstract][Full Text] [Related]
19. Pyrophosphate-bridged complexes with picomolar toxicity.
Ikotun OF; Higbee EM; Ouellette W; Doyle RP
J Inorg Biochem; 2009 Sep; 103(9):1254-64. PubMed ID: 19666193
[TBL] [Abstract][Full Text] [Related]
20. 3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity.
Rocha FV; Barra CV; Netto AV; Mauro AE; Carlos IZ; Frem RC; Ananias SR; Quilles MB; Stevanato A; da Rocha MC
Eur J Med Chem; 2010 May; 45(5):1698-702. PubMed ID: 20116142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
